Product Information

INDERAL LA 120 MG CAPSULE is a brand product labeled by ANI Pharmaceuticals, Inc., priced at $77.6159 per EA under NDC 62559052230. Its NADAC has been published 65 times since May 21, 2025.

FDA first approved this application on Apr 19, 1983. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The High Outlier badge above means this manufacturer's average price in the propranolol hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

INDERAL LA 120 MG CAPSULE

propranolol hydrochloride
$77.6159per EA
High Outlier

Strength

120 mg/1

NDC

62559052230

Classification

Brand

Dosage Form

CAPSULE, EXTENDED RELEASE

Route

ORAL

Effective Date

8/20/2025

Active Ingredients

PROPRANOLOL HYDROCHLORIDE

Approval Type

New Drug (NDA)

FDA Application

NDA018553

FDA Approved

4/19/1983

TE Code

AB

On Market Since

4/28/2017

Pharmacological Classes

Adrenergic beta-Antagonists
beta-Adrenergic Blocker

Price Statistics

The NADAC for INDERAL LA 120 MG CAPSULE has been published 65 times since May 21, 2025, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.

Current price$77.6159 per EA
All-time high$77.6159 (Aug 12, 2026)
All-time low$77.6159 (May 21, 2025)
52-week high$77.6159
52-week low$77.6159
Median price$77.6159
Average price$77.6159
Largest weekly change0.0% (May 28, 2025)
Weeks tracked65
Tracking sinceMay 21, 2025

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

0.0%

1Y

0.0%

3Y

N/A

5Y

N/A

All

0.0%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of INDERAL LA 120 MG CAPSULE?

The current National Average Drug Acquisition Cost (NADAC) for INDERAL LA 120 MG CAPSULE, manufactured by ANI Pharmaceuticals, Inc., is $77.6159 per EA (NDC 62559052230), effective Aug 12, 2026.

How has the price of INDERAL LA 120 MG CAPSULE changed over time?

Over the history we have for it, the NADAC for INDERAL LA 120 MG CAPSULE has held within roughly two percent of its current level. It has been tracked across 65 weekly CMS publications since May 21, 2025.

What are the highest and lowest recorded NADAC prices for INDERAL LA 120 MG CAPSULE?

Since May 21, 2025, the NADAC for INDERAL LA 120 MG CAPSULE has ranged from a low of $77.6159 (May 21, 2025) to a high of $77.6159 (Aug 12, 2026), with a median of $77.6159 per EA.

Are there cheaper alternatives to INDERAL LA 120 MG CAPSULE?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PROPRANOLOL ER 120 MG CAPSULE, is $0.1839 per EA — about 99% below INDERAL LA 120 MG CAPSULE.

Who manufactures INDERAL LA 120 MG CAPSULE?

INDERAL LA 120 MG CAPSULE (NDC 62559052230) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a brand product.